India sixth among major investment partners in Trump's $11.3 trillion US investment push: White HouseUnder Donald Trump's administration, the United States secured USD 11.3 trillion in investments from various countries. Among these, India ...
16 Oct, 2026, 02.17 PM IST
These large- and mid-cap stocks can give more than 20% return in 1 year, according to analystsThe next few weeks are critical, and one should not be in a hurry to make market-related decisions. Better to be cautious – to wait and wat...
16 Oct, 2026, 10.12 AM IST
Can Bonfiglioli Transmissions IPO deliver long-term growth for high-risk investors?Bonfiglioli Transmissions aims to raise Rs2,534 crore through an upcoming offer for sale. The promoter group's stake will reduce from 100% ...
16 Oct, 2026, 07.25 AM IST
Long-term investing is about looking beyond narratives, including AI: 5 large-caps with an upside potential of up to 24%As we see a recovery in the market, it is good to be cognizant of the fact that more than the narratives on the street, it is the earnings ...
15 Oct, 2026, 04.19 PM IST
Biocon settles US patent dispute with Roche's Genentech, eyes 2027 Perjeta biosimilar launchBiocon announced a settlement with Genentech over its biosimilar, Pebrilzo, of the cancer drug Perjeta. The agreement allows Biocon to laun...
15 Oct, 2026, 07.21 AM IST
Modi govt’s 13 strategic disinvestments in 10 yearsThe Modi government is set to sell a 60.72% stake in IDBI Bank for ₹52,878 crore. This sale will surpass previous disinvestment efforts, ma...
14 Oct, 2026, 08.54 PM IST
No love for the middle: CPHI Milan exposes India’s pharma scaling challengeIndian pharma and chemical companies at CPHI Milan say the China+1 opportunity is real, but a “missing middle” in the MSME ecosystem, marke...
14 Oct, 2026, 08.28 PM IST
India, America expanding cooperation across sectors: US ambassador Sergio GorKolkata and the United States are strengthening ties across sectors such as defence, IT, and healthcare. Recent military exercises involvin...
13 Oct, 2026, 10.15 AM IST
Jefferies lists 6 factors that will shape CRDMO winners; Divi’s Labs, Sai Life, Laurus, Anthem among stocks to watchIndia's CRDMO sector is on the brink of expansion, backed by solid partnerships with major pharmaceutical players and comprehensive capabil...
13 Oct, 2026, 10.10 AM IST
NuSynth Technologies raises Rs 36.5 crore in round led by Avaana Capital, Shastra VCThe company is developing a platform to find simpler, cheaper and more efficient ways to make chemicals, said cofounders Poorvank Purohit a...
13 Oct, 2026, 10.07 AM IST
'Stay tuned for...': US envoy Sergio Gor on India-US ties after Modi-Trump talksUS Ambassador Sergio Gor emphasized the strengthening collaboration between India and America in defense and healthcare sectors. During an ...
12 Oct, 2026, 11.27 PM IST
5 stocks with consistent score improvement and upside potential of up to 34% in 1 year, according to analystsGiven the current global and domestic situation, the chances are that the volatility quotient in the market will remain high. So, the best ...
12 Oct, 2026, 03.24 PM IST
Indian pharma's risk aversion holding back innovation: Kiran Mazumdar-ShawBiocon chairperson Kiran Mazumdar-Shaw calls for greater use of digital technology to speed up drug development, as industry leaders push f...
11 Oct, 2026, 12.16 AM IST
Form panel to curb pharma freebies: SCThe Supreme Court has ordered the government to establish a committee to investigate unethical pharmaceutical marketing. The committee is t...
09 Oct, 2026, 12.00 AM IST
CPHI Milan: Beyond generics, how Indian pharma is rewriting its global playbookAt CPHI Milan, Indian pharma players are looking beyond traditional exports, using partnerships, licensing, CDMO, and differentiated produc...
08 Oct, 2026, 04.29 PM IST
Supreme Court seeks committee to curb pharma firms’ unethical marketing practicesThe Supreme Court has directed the government to form a committee regarding pharmaceutical marketing regulations. This follows concerns ove...
08 Oct, 2026, 11.26 AM IST
When nothing is cheap, winners may come from any corner: 19 stocks with downside to upside potential of -28% to plus 22%Because each pharma company took a different road, they no longer rise and fall together. Where any one of them stands in 10 years depends ...
07 Oct, 2026, 05.28 PM IST